Psychotropic drugs on in vitro brain-derived neurotrophic factor production in whole blood cell cultures from healthy subjects

Journal of Clinical Psychopharmacology

Volumn 30, Issue 5, 2010, Pages 623-627

  Lee, Bun Hee ^a   Myint, Aye Mu ^b   Kim, Yong Ku ^a,c  

^a Korea University College of Medicine   (South Korea)

^b UNIVERSITY OF MUNICH   (Germany)

^c Korea University   (South Korea)

Author keywords

antidepressant; antipsychotics; BDNF; whole blood

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; HALOPERIDOL; MIRTAZAPINE; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; VENLAFAXINE;

ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BRAIN; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SERUM;

ADULT; BLOOD CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; YOUNG ADULT;

EID: 77957283200     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181f13f0b     Document Type: Article

References (29)

1. Altar CA. Neurotrophins and depression. Trends Pharmacol Sci. 1999;20: 59-61.
2. Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189: 865-870. (Pubitemid 29189691)
3. Besser M, Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and TH1/TH2-polarized expression of their receptors. J Immunol. 1999;162: 6303-6306. (Pubitemid 29309346)
4. Shibata A, Zelivyanskaya M, Limoges J, et al. Peripheral nerve induces macrophage neurotrophic activities: regulation of neuronal process outgrowth, intracellular signaling and synaptic function. J Neuroimmunol. 2003;142: 112-129. (Pubitemid 38368594)
5. Chen B, Dowlatshahi D, MacQueen GM, et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50: 260-265. (Pubitemid 32778442)
6. Dwivedi Y, Rizavi HS, Conley RR, et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60: 804-815. (Pubitemid 36960912)
7. Ruberto A, Tatarelli R, Nicoletti F, et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res. 2009;43: 247-254.
8. Pillai A, Terry AV Jr, Mahadik SP. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res. 2006;82: 95-106. (Pubitemid 43202652)
9. Parikh V, Khan MM, Mahadik SP. Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neurosci Lett. 2004;356: 135-139. (Pubitemid 38121487)
10. Pirildar S, Gonul AS, Taneli F, et al. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28: 709-713. (Pubitemid 38987396)
11. Hori H, Yoshimura R, Yamada Y, et al. Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients. Int Clin Psychopharmacol. 2007;22: 21-27. (Pubitemid 44950764)
12. Szuster-Ciesielska A, Tustanowska-Stachura A, Saotwicska M, et al. In vitro immunoregulatory effects of antidepressants in healthy volunteers. Pol J Pharmacol. 2003;55: 353-362. (Pubitemid 36975202)
13. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5: 401-412. (Pubitemid 35470359)
14. Kerschensteiner M, Stadelmann C, Dechant G, et al. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol. 2003;53: 292-304. (Pubitemid 36258633)
15. Azoulay D, Urshansky N, Karni A. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol. 2008;195: 186-193.
16. First M, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I DisorderVPatient Edition (SCID-I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1998.
17. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4: 561-571.
18. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
19. Kenis G, Steinbusch H, De-Baets M, et al. Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells. Eur Neuropsychopharmacol. 2003;13: 53-56. (Pubitemid 35449738)
20. Cooke JD, Grover LM, Spangler PR. Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus. Neuroscience. 2009;162: 1411-1419.
21. Balu DT, Hoshaw BA, Malberg JE, et al. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 2008;1211: 37-43.
22. Tsankova NM, Berton O, Renthal W, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006;9: 519-525.
23. Valvassori SS, Stertz L, Andreazza AC, et al. Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats. Metab Brain Dis. 2008;23: 213-219.
24. Park SW, Lee JG, Ha EK, et al. Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5-cells. Eur Neuropsychopharmacol. 2009;19: 356-362.
25. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11: 1169-1180.
26. Lee HY, Kim YK. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology. 2008;57: 194-199.
27. Yoshimura R, Mitoma M, Sugita A, et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 1034-1037. (Pubitemid 46824019)
28. Lee BH, Kim YK. Increased plasma brain-derived neurotropic factor, not nerve growth factor-beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology. 2009;59: 51-58.
29. Damsgaard CT, Lauritzen L, Calder PC, et al. Whole-blood culture is a valid low-cost method to measure monocytic cytokinesVa comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J Immunol Methods. 2009;340: 95-101.